Ashoo Gupta

CIK: 0002091461

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)4 (50.0%)

Position reduction

Option Exercises (M)4 (50.0%)

Derivative conversions

Awards (A)0 (0.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

FDMT

4D Molecular Therapeutics, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (8 total)

FDMT
4D Molecular Therapeutics, Inc.
Mar 20, 2026
Sale(S)
Direct
80 shares at avg. $8.61$688.8
FDMT
4D Molecular Therapeutics, Inc.
Mar 20, 2026
Exercise(M)
Direct
865 shares-
FDMT
4D Molecular Therapeutics, Inc.
Mar 20, 2026
Sale(S)
Direct
310 shares at avg. $8.61$3K
FDMT
4D Molecular Therapeutics, Inc.
Mar 20, 2026
Exercise(M)
Direct
221 shares-
FDMT
4D Molecular Therapeutics, Inc.
Dec 20, 2025
Exercise(M)
Direct
866 shares-
FDMT
4D Molecular Therapeutics, Inc.
Dec 20, 2025
Sale(S)
Direct
310 shares at avg. $8.68$3K
FDMT
4D Molecular Therapeutics, Inc.
Dec 20, 2025
Exercise(M)
Direct
220 shares-
FDMT
4D Molecular Therapeutics, Inc.
Dec 20, 2025
Sale(S)
Direct
79 shares at avg. $8.68$685.72

		Type	Shares	Price		Ownership
Mar 20, 2026	FDMT 4D Molecular Therapeutics, Inc.	Sale(S)	80	$8.61	$689	Direct
Mar 20, 2026	FDMT 4D Molecular Therapeutics, Inc.	Exercise(M)	865	-	$0	Direct
Mar 20, 2026	FDMT 4D Molecular Therapeutics, Inc.	Sale(S)	310	$8.61	$2,669	Direct
Mar 20, 2026	FDMT 4D Molecular Therapeutics, Inc.	Exercise(M)	221	-	$0	Direct
Dec 20, 2025	FDMT 4D Molecular Therapeutics, Inc.	Exercise(M)	866	-	-	Direct
Dec 20, 2025	FDMT 4D Molecular Therapeutics, Inc.	Sale(S)	310	$8.68	$2,691	Direct
Dec 20, 2025	FDMT 4D Molecular Therapeutics, Inc.	Exercise(M)	220	-	-	Direct
Dec 20, 2025	FDMT 4D Molecular Therapeutics, Inc.	Sale(S)	79	$8.68	$686	Direct

1-8 of 8 transactions

About Gupta Ashoo

Gupta Ashoo (SEC CIK 0002091461) files insider reports with the SEC as VP, Finance and Controller of 4D Molecular Therapeutics, Inc. (FDMT).

Signal8 holds 3 ownership filings by Gupta Ashoo (1 Form 3, 2 Form 4), filed between Oct 10, 2025 and Mar 24, 2026. Those filings report 8 transactions, from Dec 20, 2025 to Mar 20, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Gupta Ashoo's filings is in EMERYVILLE, CA.

Recent filings by Gupta Ashoo

Mar 20, 2026: Open-market sale of FDMT shares (Form 4, code S).
Mar 20, 2026: Option exercise of FDMT shares (Form 4, code M).
Mar 20, 2026: Open-market sale of FDMT shares (Form 4, code S).
Mar 20, 2026: Option exercise of FDMT shares (Form 4, code M).
Dec 20, 2025: Option exercise of FDMT shares (Form 4, code M).

Other insiders filing for 4D Molecular Therapeutics, Inc. (FDMT)

Bizily Scott, Chief Legal Officer
Kirn David
Tomasello Shawn, Director
THEUER CHARLES, Director
Miller-Rich Nancy, Director
GRAY SUSANNAH, Director

How to read Form 4 transaction codes